Guardant Health Inc.(GH),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

GH Guardant Health Inc.

Market Closed 05-29 16:00:00 EDT

129.69

-3.53

-2.65%

盘后125.28

-4.41-3.40%

19:58 EDT

High133.97	Low128.31	Vol3.51M
Open133.22	D1 Closing133.22	Amplitude4.25%
Mkt Cap17.19B	Tradable Cap16.47B	Total Shares132.57M
T/O456.68M	T/O Rate2.77%	Tradable Shares127.00M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"GH","market":"US","secType":"STK","nameCN":"Guardant Health Inc.","latestPrice":129.69,"timestamp":1780084800000,"preClose":133.22,"halted":0,"volume":3513787,"hourTrading":{"tag":"盘后","latestPrice":125.2788,"preClose":129.69,"latestTime":"19:58 EDT","volume":126697,"amount":16430693.0021,"timestamp":1780099096536,"change":-4.4112,"changeRate":-0.034013,"amplitude":0.034322},"delay":0,"changeRate":-0.0264975228944603,"floatShares":127000000,"shares":132573424,"eps":-3.404949,"marketStatus":"Market Closed","change":-3.53,"latestTime":"05-29 16:00:00 EDT","open":133.22,"high":133.9699,"low":128.31,"amount":456684155.63614005,"amplitude":0.042485,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-3.404949,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1780300800000},"marketStatusCode":7,"adr":0,"adrRate":0,"listingDate":1538625600000,"exchange":"NASDAQ","adjPreClose":133.22,"preHourTrading":{"tag":"盘前","latestPrice":133.63,"preClose":133.22,"latestTime":"09:15 EDT","volume":310,"amount":41616.3933,"timestamp":1780060541974,"change":0.41,"changeRate":0.003078,"amplitude":0.03113},"postHourTrading":{"tag":"盘后","latestPrice":125.2788,"preClose":129.69,"latestTime":"19:58 EDT","volume":126697,"amount":16430693.0021,"timestamp":1780099096536,"change":-4.4112,"changeRate":-0.034013,"amplitude":0.034322},"volumeRatio":1.08829587927416,"impliedVol":0.4891,"impliedVolPercentile":0.0199},"requestUrl":"/m/hq/s/GH/tweets","defaultTab":"tweets","newsList":[{"id":"2639074536","title":"Why Guardant Health (GH) Is Up 9.0% After ACS Adds Shield Test to Screening Guidelines","url":"https://stock-news.laohu8.com/highlight/detail?id=2639074536","media":"Simply Wall St.","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2639074536?lang=en_us&edition=fundamental","pubTime":"2026-05-31 13:07","pubTimestamp":1780204075,"startTime":"0","endTime":"0","summary":"In May 2026, Guardant Health announced that its FDA-approved Shield blood test was added to updated American Cancer Society colorectal cancer screening guidelines as a blood-based option for average-risk adults 45 and older who decline or do not complete traditional tests.\nThis guideline inclusion, alongside recent FDA clearance of the expanded Guardant360 Liquid CDx panel, highlights growing clinical recognition of Guardant’s blood-based cancer diagnostics across both screening and...","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/6032000-choice2-main-header/1585186864566","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6032000-choice2-main-header/1585186864566"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/healthcare/nasdaq-gh/guardant-health/news/why-guardant-health-gh-is-up-90-after-acs-adds-shield-test-t","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/healthcare/nasdaq-gh/guardant-health/news/why-guardant-health-gh-is-up-90-after-acs-adds-shield-test-t","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4588","BK4551","GH","BK4585","BK4196","BK4535"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2639567098","title":"Guardant Health director Manuel Hidalgo Medina disposes of 1,000 common shares worth $130,060.10","url":"https://stock-news.laohu8.com/highlight/detail?id=2639567098","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2639567098?lang=en_us&edition=fundamental","pubTime":"2026-05-30 05:31","pubTimestamp":1780090267,"startTime":"0","endTime":"0","summary":"Guardant Health director Manuel Hidalgo Medina sold 1,000 common shares on May 28, 2026 at USD 130.06 each.Direct holdings fell to 639 shares following the transaction.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Guardant Health Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on May 29, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260529:nNDL10ny3c:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Guardant Health director Manuel Hidalgo Medina disposes of 1,000 common shares worth $130,060.10","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4535","BK4585","BK4551","BK4196","GH","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2639614581","title":"Guardant Health Chief Legal Officer John G. Saia sells USD 1.26 million in common shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2639614581","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2639614581?lang=en_us&edition=fundamental","pubTime":"2026-05-29 06:33","pubTimestamp":1780007596,"startTime":"0","endTime":"0","summary":"Guardant Health Chief Legal Officer John G. Saia sold 10,000 common shares on May 27, 2026.Sales priced at $125.08 per share on a weighted-average basis, with an additional 6 shares sold at $126.08.Saia’s direct holdings fell to 35,950 shares following the transactions.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Guardant Health Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on May 28, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260528:nNDL90qCnM:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GH","BK4551","SAIA","BK4588","BK4585","BK4196","BK4232","LU2065731478.USD","BK4022","LU0053671581.USD","BK4535"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638695821","title":"Guardant Health to present 38 abstracts at ASCO 2026 meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2638695821","media":"TIPRANKS","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2638695821?lang=en_us&edition=fundamental","pubTime":"2026-05-28 20:35","pubTimestamp":1779971712,"startTime":"0","endTime":"0","summary":"Guardant Health (GH) announced the company and its research collaborators will present 38 abstracts, as well as one oral presentation in partnershi...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/guardant-health-to-present-38-abstracts-at-asco-2026-meeting-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/guardant-health-to-present-38-abstracts-at-asco-2026-meeting-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4551","BK4585","BK4535","BK4196","GH","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638958236","title":"Guardant Health (GH) Gets a Buy from Piper Sandler","url":"https://stock-news.laohu8.com/highlight/detail?id=2638958236","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2638958236?lang=en_us&edition=fundamental","pubTime":"2026-05-28 20:29","pubTimestamp":1779971353,"startTime":"0","endTime":"0","summary":"In a report released today, David Westenberg from Piper Sandler reiterated a Buy rating on Guardant Health, with a price target of $135.00. Accordi...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/guardant-health-gh-gets-a-buy-from-piper-sandler-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/guardant-health-gh-gets-a-buy-from-piper-sandler-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4588","BK4551","BK4196","GH","BK4585","BK4535"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638698717","title":"Guardant Health set to present 38 abstracts at ASCO annual meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2638698717","media":"Reuters","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2638698717?lang=en_us&edition=fundamental","pubTime":"2026-05-28 20:09","pubTimestamp":1779970152,"startTime":"0","endTime":"0","summary":"Guardant Health will attend the ASCO Annual Meeting in Chicago, May 29 to June 2, 2026.The company plans to present 38 abstracts, including one oral presentation with Pfizer, highlighting liquid biopsy advances powered by InfinityAI.Data include analytical validation supporting Guardant360 Liquid CDx as a pan-cancer companion diagnostic following recent FDA approval.Additional presentations cover improved ALK fusion detection in NSCLC, methylation-based tumor classification, tissue-free MRD monitoring, recurrence tracking.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Guardant Health Inc. published the original content used to generate this news brief on May 28, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260528:nNDL88ZsDQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4196","GH","BK4535","BK4588","BK4585","BK4551"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638034660","title":"Canaccord Genuity Reaffirms Their Buy Rating on Guardant Health (GH)","url":"https://stock-news.laohu8.com/highlight/detail?id=2638034660","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2638034660?lang=en_us&edition=fundamental","pubTime":"2026-05-28 19:40","pubTimestamp":1779968428,"startTime":"0","endTime":"0","summary":"In a report released today, Kyle Mikson CFA from Canaccord Genuity reiterated a Buy rating on Guardant Health, with a price target of $135.00. Miks...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/canaccord-genuity-reaffirms-their-buy-rating-on-guardant-health-gh-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/canaccord-genuity-reaffirms-their-buy-rating-on-guardant-health-gh-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["GH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638660086","title":"Analysts Are Bullish on Top Healthcare Stocks: Niagen Bioscience (NAGE), Guardant Health (GH)","url":"https://stock-news.laohu8.com/highlight/detail?id=2638660086","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2638660086?lang=en_us&edition=fundamental","pubTime":"2026-05-28 19:40","pubTimestamp":1779968405,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Niagen Bioscience (NAGE), Guardant Health (GH) and B...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-are-bullish-on-top-healthcare-stocks-niagen-bioscience-nage-guardant-health-gh-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-are-bullish-on-top-healthcare-stocks-niagen-bioscience-nage-guardant-health-gh-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["NAGE","GH","BK4588","BK4196","BK4535","BK4585","BK4121","BK4551","BK4183"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1146659061","title":"Movement Alert｜Guardant Health Rises 5.87% in Pre-Market Trading, Shield Blood Test Included in American Cancer Society Screening Guidelines","url":"https://stock-news.laohu8.com/highlight/detail?id=1146659061","media":"Market Focus","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1146659061?lang=en_us&edition=fundamental","pubTime":"2026-05-28 16:35","pubTimestamp":1779957334,"startTime":"0","endTime":"0","summary":"On May 28, Guardant Health rose 5.87% in pre-market trading, trading at $127.78/share, with trading volume of $84,800.On the news front, the company announced that its Shield blood test has been...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638870376","title":"Guardant Health Is Maintained at Buy by BTIG","url":"https://stock-news.laohu8.com/highlight/detail?id=2638870376","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2638870376?lang=en_us&edition=fundamental","pubTime":"2026-05-28 01:37","pubTimestamp":1779903420,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/GH/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  May 27, 2026 13:37 ET (17:37 GMT)","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4196","GH","BK4535","BK4551","BK4588","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638368787","title":"Guardant Health price target raised to $160 from $155 at BTIG","url":"https://stock-news.laohu8.com/highlight/detail?id=2638368787","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2638368787?lang=en_us&edition=fundamental","pubTime":"2026-05-28 00:52","pubTimestamp":1779900759,"startTime":"0","endTime":"0","summary":"BTIG raised the firm’s price target on Guardant Health (GH) to $160 from $155 and keeps a Buy rating on the shares. The American Cancer Society upd...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/guardant-health-price-target-raised-to-160-from-155-at-btig-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/guardant-health-price-target-raised-to-160-from-155-at-btig-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4588","BK4551","GH","BK4585","BK4196","BK4535"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1151225048","title":"Movement Alert｜Guardant Health Rises 5.26% in Regular Trading, Shield Blood Test Included in American Cancer Society Screening Guidelines","url":"https://stock-news.laohu8.com/highlight/detail?id=1151225048","media":"Market Focus","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1151225048?lang=en_us&edition=fundamental","pubTime":"2026-05-28 00:47","pubTimestamp":1779900477,"startTime":"0","endTime":"0","summary":"On May 28, Guardant Health rose 5.26% in regular trading, trading at $126.21 per share, with trading volume of $191 million.On the news front, the company announced that its Shield blood test has...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638810685","title":"Exchange-Traded Funds, Equity Futures Higher Pre-Bell Amid S&P 500, Nasdaq Rally, Middle East Peace Optimism","url":"https://stock-news.laohu8.com/highlight/detail?id=2638810685","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2638810685?lang=en_us&edition=fundamental","pubTime":"2026-05-27 21:29","pubTimestamp":1779888590,"startTime":"0","endTime":"0","summary":"The broad market exchange-traded fund SPDR S&P 500 ETF Trust (SPY) was up 0.7%, and the actively traded Invesco QQQ Trust (QQQ) was 1.7% higher in Wednesday's premarket activity amid all-time highs ac","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"f6f7c9f6a0174df79daf9f1dfd21f836","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["PDD","RTH","EETH","FAZ","VOO","NQmain","GLD","VYM","VHT","XRT","OP.USD.HKCC","EQR","IYJ","BITO","SOXX","XLF","RTH.AU","XLP","SPY","QQQ","IYE","VDC","IGM","FAS","USO","VHT.AU","BETH","XLE","XLI","VOOG","QFIN","IYH","TTE","XLY","XSD","DY","SLV","VIS","IBB","IYK",".SPX","IYW","VUG","XLV","SCHG","GH","XLK","UNG","MU","SPY.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638683444","title":"Sector Update: Health Care Stocks Mixed Premarket Wednesday","url":"https://stock-news.laohu8.com/highlight/detail?id=2638683444","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2638683444?lang=en_us&edition=fundamental","pubTime":"2026-05-27 21:17","pubTimestamp":1779887879,"startTime":"0","endTime":"0","summary":"Healthcare stocks were mixed premarket Wednesday, with the State Street Health Care Select Sector SPDR ETF  0.2% lower and the iShares Biotechnology ETF  up 0.5%.Guardant Health  shares were up more than 5% after the company said its Shield blood test has been included in the American Cancer Society's updated Colorectal Cancer Screening guidelines.TG Therapeutics'  Phase 3 ENHANCE trial met its primary endpoint, demonstrating bioequivalent drug exposure between the approved two-infusion initiation regimen for Briumvi and a proposed single Day 1 infusion dosing schedule, the company said. TG Therapeutics stock was up more than 1% pre-bell.Nuvalent  shares were up more than 1% after the company said the US Food and Drug Administration accepted for filing its New Drug Application for neladalkib, an investigational ALK-selective inhibitor in tyrosine kinase inhibitor pre-treated advanced ALK-positive non-small cell lung cancer.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"f6f7c9f6a0174df79daf9f1dfd21f836","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4581","IBB","BK4551","BK4585","BK4539","XLV","BK4588","BK4535","BK4196","XBI","LABU","BK4139","GH","TGTX","NUVL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638500741","title":"Guardant Health Says Shield Blood Test Included in American Cancer Society Guidelines","url":"https://stock-news.laohu8.com/highlight/detail?id=2638500741","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2638500741?lang=en_us&edition=fundamental","pubTime":"2026-05-27 20:32","pubTimestamp":1779885153,"startTime":"0","endTime":"0","summary":"Guardant Health  said Wednesday that its Shield blood test has been included in the American Cancer Society's updated Colorectal Cancer Screening guidelines.The guidelines recommend Shield as an option for patients who decline or have not completed stool-based or visual examination screening tests for colorectal cancer, the company said.Shares of the company were up 4% in Wednesday's premarket activity.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"f6f7c9f6a0174df79daf9f1dfd21f836","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4535","BK4117","BK4585","GH","BK4588","AFG","BK4107","BK4196","BK4551"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638503333","title":"Guardant Health FDA Win Sparks Interest In Liquid Biopsy Valuation Gap","url":"https://stock-news.laohu8.com/highlight/detail?id=2638503333","media":"Simply Wall St.","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2638503333?lang=en_us&edition=fundamental","pubTime":"2026-05-27 16:10","pubTimestamp":1779869401,"startTime":"0","endTime":"0","summary":"Guardant Health (NasdaqGS:GH) received FDA approval for its Guardant360 Liquid CDx test, described as the most comprehensive blood-based cancer profiling test integrating genomic and epigenomic data.\nThe approval covers advanced cancer care and expands the test's use as a companion diagnostic across multiple cancer types.\nThe platform uses AI-enabled multiomic technology to combine genomic and epigenomic insights in a single liquid biopsy.\n\nGuardant Health focuses on liquid biopsy...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/6032000-choice2-main-header/1585186864566","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6032000-choice2-main-header/1585186864566"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/healthcare/nasdaq-gh/guardant-health/news/guardant-health-fda-win-sparks-interest-in-liquid-biopsy-val","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/healthcare/nasdaq-gh/guardant-health/news/guardant-health-fda-win-sparks-interest-in-liquid-biopsy-val","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4535","BK4588","BK4585","LABU","BK4196","GH","BK4551"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638232445","title":"Guardant Health Chief Commercial Officer Chris Freeman disposes of 24,406 common shares worth $2.9 million","url":"https://stock-news.laohu8.com/highlight/detail?id=2638232445","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2638232445?lang=en_us&edition=fundamental","pubTime":"2026-05-27 05:38","pubTimestamp":1779831513,"startTime":"0","endTime":"0","summary":"Guardant Health Chief Commercial Officer Chris Freeman exercised stock options for 24,406 shares at $32.86 on May 22, 2026.Freeman sold 24,406 shares at an average $118.67 on the same day.He ended the day with 60,034 shares of common stock.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Guardant Health Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on May 26, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260526:nNDL245v6c:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Guardant Health Chief Commercial Officer Chris Freeman disposes of 24,406 common shares worth $2.9 million","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4535","BK4585","BK4588","GH","BK4551","BK4196"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638516226","title":"Guardant Health Is Maintained at Buy by BTIG","url":"https://stock-news.laohu8.com/highlight/detail?id=2638516226","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2638516226?lang=en_us&edition=fundamental","pubTime":"2026-05-26 19:04","pubTimestamp":1779793440,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/GH/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  May 26, 2026 07:04 ET (11:04 GMT)","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GH","BK4585","BK4588","BK4535","BK4196","BK4551"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638515151","title":"Guardant Health Inc : Btig Raises Target Price to $155 From $145","url":"https://stock-news.laohu8.com/highlight/detail?id=2638515151","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2638515151?lang=en_us&edition=fundamental","pubTime":"2026-05-26 18:39","pubTimestamp":1779791992,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260526:nFWN4230BV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4588","BK4585","BK4196","BK4535","GH","BK4551"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637750193","title":"Assessing Guardant Health (GH) Valuation After A Strong Share Price Run","url":"https://stock-news.laohu8.com/highlight/detail?id=2637750193","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2637750193?lang=en_us&edition=fundamental","pubTime":"2026-05-24 04:15","pubTimestamp":1779567353,"startTime":"0","endTime":"0","summary":"Event context and recent stock performance\nGuardant Health (GH) has drawn investor attention after recent trading, with the stock closing at US$118.95 and showing gains over the past month and past 3 months.\nSee our latest analysis for Guardant Health.\nThe recent move to US$118.95 follows a strong run, with a 7 day share price return of 25.32% and a 1 year total shareholder return of 213.03%, suggesting momentum has been building rather than fading.\nIf Guardant Health’s surge has you thinking...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/6032000-choice2-main-header/1585186864566","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6032000-choice2-main-header/1585186864566"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/healthcare/nasdaq-gh/guardant-health/news/assessing-guardant-health-gh-valuation-after-a-strong-share","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/healthcare/nasdaq-gh/guardant-health/news/assessing-guardant-health-gh-valuation-after-a-strong-share","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4196","BK4588","BK4551","GH","BK4585","BK4535"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.guardanthealth.com","stockEarnings":[{"period":"1week","weight":0.0903},{"period":"1month","weight":0.5548},{"period":"3month","weight":0.3812},{"period":"6month","weight":0.1962},{"period":"1year","weight":2.3642},{"period":"ytd","weight":0.2697}],"compareEarnings":[{"period":"1week","weight":0.0145},{"period":"1month","weight":0.0631},{"period":"3month","weight":0.1028},{"period":"6month","weight":0.107},{"period":"1year","weight":0.2821},{"period":"ytd","weight":0.1093}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Guardant Health, Inc., a precision oncology company, provides blood and tissue tests, data sets, and analytics in the United States and internationally. The company provides Guardant360; Guardant360 LDT; Guardant360 CDx Test; Guardant360 Response Test; Guardant360 TissueNext Test; GuardantINFINITY Test; GuardantConnect, an integrated software-based solution designed for clinical and biopharmaceutical customers to connect patients tested with assays with actionable alterations with potentially relevant clinical studies; GuardantOMNI Test for advanced stage cancer; and GuardantINFORM, an in-silico research platform for tumor evolution and treatment resistance across various biomarker-driven cancers. It offers Shield Test; Guardant Reveal Test for adjuvant treatment selection in early-stage cancer patients; Smart Liquid Biopsy Platform; and Guardant Galaxy, an AI-backed digital pathology platform that helps improve cancer biomarker detection. In addition, the company offers development services, including companion diagnostic development and regulatory approval, clinical study setup, monitoring and maintenance, testing development and support, technologies licensing, and kits fulfillment. The company has a collaboration agreement with Illumina, Inc. for the sharing of specimen samples to advance cancer research. The company was incorporated in 2011 and is headquartered in Palo Alto, California.","yearOnYearQuotes":[{"month":1,"riseRate":0.625,"avgChangeRate":0.071093},{"month":2,"riseRate":0.25,"avgChangeRate":0.034152},{"month":3,"riseRate":0.5,"avgChangeRate":-0.022808},{"month":4,"riseRate":0.375,"avgChangeRate":-0.022604},{"month":5,"riseRate":0.625,"avgChangeRate":0.118443},{"month":6,"riseRate":0.714286,"avgChangeRate":0.081894},{"month":7,"riseRate":0.714286,"avgChangeRate":0.051469},{"month":8,"riseRate":0.571429,"avgChangeRate":0.08346},{"month":9,"riseRate":0.285714,"avgChangeRate":-0.065825},{"month":10,"riseRate":0.285714,"avgChangeRate":0.030366},{"month":11,"riseRate":0.75,"avgChangeRate":0.130427},{"month":12,"riseRate":0.5,"avgChangeRate":-0.066498}],"exchange":"NASDAQ","name":"Guardant Health Inc.","nameEN":"Guardant Health Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.42.3","shortVersion":"4.42.3","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Guardant Health Inc.(GH),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Guardant Health Inc.(GH) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Guardant Health Inc.,GH,Guardant Health Inc.股票,Guardant Health Inc.股票老虎,Guardant Health Inc.股票老虎国际,Guardant Health Inc.行情,Guardant Health Inc.股票行情,Guardant Health Inc.股价,Guardant Health Inc.股市,Guardant Health Inc.股票价格,Guardant Health Inc.股票交易,Guardant Health Inc.股票购买,Guardant Health Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Guardant Health Inc.(GH),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Guardant Health Inc.(GH) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}